Creative Planning
DRTX

Creative Planning’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Creative Planning’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-500
Closed -$9K – 4330
2014
Q2 		$9K Buy
+500
New +$7.44K ﹤0.01% 2967

Other funds holding DRTX

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return

Creative Planning's DRTX Position: Q3 2014 in Review

Creative Planning sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q3 2014, closing a stake of 500 shares — an estimated $9K sold.

Creative Planning first reported a position in DRTX in Q2 2014 and held it in 1 quarter. The position peaked at $9K in Q2 2014. 70 funds tracked by Wall St. Rank hold DRTX as of Q3 2014.

  • Creative Planning reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Creative Planning sold 500 DURATA THERAPEUTICS INC COM STK (DE) shares in Q3 2014, an estimated $9K.
  • Creative Planning first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Creative Planning's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $9K in Q2 2014.
  • 70 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q3 2014.

Based on Creative Planning's 13F filing for Q3 2014, filed 10 Oct 2014.